Para-[18F]fluorobenzylguanidine kinetics in a canine coronary artery occlusion model
Tóm tắt
The kinetics of para-[18F]fluorobenzylguanidine ([18F]PFBG) were investigated in a canine coronary artery occlusion model. Five dogs were imaged by positron emission tomography (PET) before and after complete surgical ligation of the left anterior descending coronary artery. PET studies included a 10-minute dynamic [13N]NH3 perfusion scan, followed 1 hour later by 3-hour dynamic [18F]PFBG scanning. [18F]PFBG and [13N]NH3 images demonstrated homogeneous myocardial uptake/perfusion before infarction. One hundred eighty minutes after [18F]PFBG administration, myocardial accumulation was decreased by 60% (day, 2, 0.0065% ±0.0015% injected dose/ml) and 58% (day 16, 0.0069%±0.003% injected dose/ml) compared with a similar myocardial region of interest from the preinfarction (0.016%±0.005% injected dose/ml) study. Myocardial accumulation of [13N]NH3 at 9 minutes showed a 52% (day 2) and 7% (day 16) decrease compared with the preinfarction study. The accumulation of [18F]PFBG in the infarction was decreased significantly at 120 and 180 minutes on all postinfarction studies (p=0.01). In three dogs a significant decrease in the myocardial norepinephrine concentration was documented in the area of infarction (237±94 ng/gm) versus the noninfarcted (1018±48 ng/gm) myocardium (p=0.001). A decreased accumulation of [18F]PFBG was observed in the area of myocardial infarct in this canine model. The magnitude of the decrease in [18F]PFBG was larger than that seen with [13N]NH3 on day 16 after infarction suggesting reperfusion and persistent sympathetic neuronal dysfunction.
Tài liệu tham khảo
Wieland DM, Wu JL, Brown EL, et al. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with (I-125) iodobenzylguanidine. J Nucl Med 1980;21:349–53.
DeGrado TR, Zalutsky MR, Vaidyanathan G. Uptake mechanisms of meta-[123I]-iodobenzylguanidine in isolated rat heart. Nucl Med Biol 1995;22:1–12.
Trendelenburg U. Extraneuronal uptake and metabolism of catecholamines as a site of loss. Life Sci 1978;22:1217–22.
Dae MW, DeMarco T, Botvinick EH, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: implications for clinical studies. J Nucl Med 1992;33:1444–50.
Minardo JD, Tuli MM, Mock BH, et al. Scinitigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 1988;78:1008–19.
Newman D, Munoz L, Chin M, et al. Effects of canine myocardial infarction on sympathetic efferent neuronal function: scintigraphic and electrophysiological correlates. Am Heart J 1993;126:1106–12.
Sisson JC, Wieland DM, Koeppe RA, et al. Scintigraphic portrayal of beta receptors in the heart. J Nucl Med 1991;32:1399–407.
Stanton MS, Tuli MM, Radtke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively by I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:1519–26.
Merlet P, Valette H, Dubois-Randé J-L., et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471–7.
Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 1989;30:1182–91.
Ding Y-S, Fowler JS, Dewey SL, et al. Comparison of high specific activity (+)- and (−)-6-[18F]fluoronorepinephrine and 6-[18F]fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine. J Nucl Med 1993;34:619–29.
Schwaiger M, Kalff V, Rosenspire K, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 1990;82:457–64.
Wieland DM, Rosenspire KC, Hutchins GD. Neuronal mapping of the heart with 6-[18F]fluorometaraminol. J Med Chem 1990;33:956–4.
Valette H, Loc'h C, Mardon K, et al. Bromine-76-metabromo-benzylguanidine: a PET radiotracer for mapping sympathetic nerves of the heart. J Nucl Med 1993;34:1739–44.
Garg PK, Garg S, Zalutsky MR. Synthesis and preliminary evaluation of para- and meta-[F-18]fluorobenzylguanidine. Nucl Med Biol 1994;21:97–103.
Garg PK, Berry CR, DeGrado TR, et al. Myocardial and adrenal uptake of para-[18F]-fluorobenzylguanidine in the dog [Abstract]. J. Nucl Med 1994;35:255P.
Garg PK, Berry CR, Garg S, DeGrado TR, Zalutsky MR, Coleman RE. Para-[18F]-fluorobenzylguanidine ([18F]PFBG): further evaluation of a potential PET radiotracer in dogs. Proc Int Cancer Congr 1994;16:113–8.
Logan J, Fowler JS, Volkow ND, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(−)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990;10:740–7.
DeGrado TR, Garg PK, Berry CR, Zalutsky MR, Coleman RE. Compartmental model estimation and parametric imaging of distribution volume of sympathetic neuronal tracer para-[F-18]fluorobenzylguanidine (PFBG) in canine myocardium [Abstract]. J Nucl Med 1995;36:38P.
Dae MW, Herre JM, O'Connell JW, et al. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol 1991;17:1416–23.
Dae MW, O'Connell JW, Botrinick EH, et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 1989;79:634–44.
Krvokapich J, Smith GT, Huang SC, et al. N-13 ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989;80:1328–37.
Hutchins GD, Schwaiger M, Rosenspire KC, et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1031–42.
Kaye MP, Tyce GM. Norepinephrine uptake as an indicator of cardiac reinnervation in dogs. Am J Physiol 1978;2356:H289–94.
Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C] flumezenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991; 11:735–44.
Schwaiger M, Guibourg H, Rosenspire K, et al. Effect of regional myocardial ischemia on sympathetic nervous system as assessed by fluorine-18-metaraminol. J Nucl Med 1990;31:1352–7.
DeGrado TR, Berry CR, Garg PK, Zalutsky MR, Coleman RE. Uptake and retention mechanisms of para-[18F]fluorobenzyl-guanidine (PFBG) in rat heart [Abstract]. J Nucl Med 1995;39:22–4.